
In the phase 2b EVIDENCES X trial, saroglitazar 4 mg resolved MASH without worsening fibrosis in 39.1% of patients vs 13.7% with placebo at 52 weeks.
View slated expert interviews and 6 clinical GI, hepatology, and endoscopy trials to watch at ACG 2025.
The American College of Gastroenterology (ACG)’s 2025 Annual Scientific Meeting kicks off in Phoenix, Arizona, on Monday, October 27, 2025. Coined as the premier GI clinical event of the year, the 3-day conference will feature the hottest topics in clinical GI, hepatology, and endoscopy, with updates delivered by internationally known faculty and rising stars in each of these spaces.






